Share this article

Market insight in association with

Obstacle course for sperm is helping IVF scientists find the best swimmers

In vitro fertilization (IVF) refers to procedures that assist with the fertilisation of an embryo. IVF involves the collection of eggs from the ovaries and subsequent fertilisation by sperm and is carried out in a laboratory setting. Once the process is complete, the fertilised egg is transplanted into a uterus with the goal of embryo development. The entire IVF cycle usually takes two to three weeks.

Chances of success?

The success of IVF depends on multiple factors, including age and the reasons for infertility. Since IVF is an expensive process, costing over $10,000 on average, it is important for the procedure to be as efficient as possible to reduce the need for multiple IVF cycles. The Centers for Disease Control and Prevention (CDC) estimate that 12% of women in the US aged 15–44 years have difficulty becoming pregnant.


The World Health Organization (WHO) indicates that more than 10% of women are infertile or experience subfertility. Male infertility is also a contributing factor, as the National Institute of Health (NIH) estimates that 40% of infertility cases are due to male infertility.

Putting microfluidics to work

Recent advances in IVF include the development of devices that increase the success rate for IVF. Researchers at Stanford University, US, developed a device that can select for healthy sperm to be used in IVF.


The device, named Simple Periodic Array for Trapping and Isolation (SPARTAN), is based on the principle of microfluidics.


While several microfluidic devices already exist, these platforms are complicated and often require pumps or chemicals that can be damaging to sperm.

Microchip obstacle course

The SPARTAN system uses a series of obstacles on a microchip, requiring sperm to swim around pillar-shaped objects and through the device.


As a result, this device promotes the collection of the highest quality sperm. Another advantage of this procedure is that raw, non-frozen samples are used, thus maintaining the integrity of fresh sperm. Authors of the study indicate that the overall selection process is very short (around 10 minutes) and results in 99% of collected sperm being highly motile.


Additionally, the collected sperm have enhanced morphology and DNA integrity compared to sperm collected via other methods. The lead researchers who published their results on the SPARTAN device in 2017 have since become a part of ZyMot Fertility, a division of DxNow, Inc. In 2018, the company received US Food and Drug Administration (FDA) approval for sperm separation devices based on the SPARTAN technology.

For more insight and data, visit the GlobalData Report Store.

Go to article: Home | Deep Space DiagnosticsGo to article: In this issueGo to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: Contents Go to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: Critical Software Company Insight Go to article: Critical SoftwareGo to article: NewsGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: Omnitron Go to article: The Medical Industry Briefing Go to article: Sab BroeckskesGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: Exceeding expectations: home sperm testing in the fertility tech marketGo to article: Siemens Company Insight Go to article: Siemens Go to article: Micro Systems TechnologiesGo to article: Space simulation: how gaming tech is being used to medically train astronautsGo to article: Braxton Manufacturing Go to article: CaelesteGo to article: Duodenoscopes: a dirty problemGo to article: Nelson Labs Company InsightGo to article: Nelson Labs Go to article: Mobile mind control: material engineering meets neurobiology Go to article: Abbott & CoGo to article: IMT Company InsightGo to article: IMTGo to article: Breathe easy: improving at-home asthma managementGo to article: Erdmann Design Company Insight Go to article: Erdmann Design Go to article: Q&A: the challenge of foetal monitoring with Professor Barrie Hayes-GillGo to article: Protomatic Medical Company InsightGo to article: Protomatic MedicalGo to article: Roundtable: debating the benefits of the NHS’s newly launched AI labGo to article: Europlasma Company Insight Go to article: EuroplasmaGo to article: The long road to reliable organ printingGo to article: SartoriusGo to article: Cap BiomaterialsGo to article: URGENT/11 vulnerabilities showcase cybersecurity risks for connected medical devicesGo to article: Telemed Company InsightGo to article: TelemedGo to article: Admedus turns focus to TAVR market with next-generation tissue technologyGo to article: Turck Duotec Company Insight Go to article: Turck DuotecGo to article: 3BYGo to article: Medtronic’s extravascular ICD is pushing innovationGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO Go to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Obstacle course for sperm is helping IVF scientists find the best swimmersGo to article: MicronovaGo to article: ARPA Company InsightGo to article: ARPAGo to article: Varian enters the embolisation particles marketGo to article: Ginolis Company InsightGo to article: GinolisGo to article: Verdict Insights: The latest verdict insight from Medical Technology Go to article: TEN MedPrint Company Insight Go to article: TEN MedPrint Go to article: Future of healthcare: What will medicine look like in 2040?Go to article: GF Machining Solutions Company InsightGo to article: GF Machining Solutions Go to article: 3D printing: Bringing assistive technology to the developing worldGo to article: iTAC Software Go to article: CarmoGo to article: Stepping up anatomical 3D printingGo to article: Key Plastics Company Insight Go to article: Key PlasticsGo to article:  Coaxial Electrospinning: Revolutionising MedicineGo to article: SARA: The robot targeting European elderly careGo to article: ClippardGo to article: Bright PlasticsGo to article: Asahi InteccGo to article: Bias in the system: the leading healthcare algorithm with bias against black patientsGo to article: Mdeg Digital Go to article: Maraca InternationalGo to article: OptelGo to article: Body cameras: The benefits in mental healthcareGo to article: CleanControlling MedicalGo to article: Abatek InternationalGo to article: XavitechGo to article: Take a seat: The mental health chatbots encroaching on the therapist’s couchGo to article: mdi ConsultantsGo to article: MK FluidicsGo to article: AI for sight: The technology transforming infant eye disorder diagnosisGo to article: ProByLas Go to article: ITV Denkendorf ProduktserviceGo to article: Deals in brief powered by GlobalDataGo to article: TS Quality & EngineeringGo to article: Mi3 Medical IntelligenceGo to article: The key list powered by GlobalDataGo to article: AerogelexGo to article: EventsGo to article: PI CeramicGo to article: Next issueGo to article: Qmedics Company Insight Go to article: QmedicsGo to article: Tresky